The PPAR(gamma) K422Q mutation does not contribute to troglitazone inefficiency in colon cancer treatment (Q46505102)

From Wikidata
Jump to navigation Jump to search
scientific article published in June 2005
edit
Language Label Description Also known as
English
The PPAR(gamma) K422Q mutation does not contribute to troglitazone inefficiency in colon cancer treatment
scientific article published in June 2005

    Statements

    The PPAR(gamma) K422Q mutation does not contribute to troglitazone inefficiency in colon cancer treatment (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit